Teriflunomide in patients with multiple sclerosis
The article discusses the prospects for the use of the new drug teriflunomide for the treatment of patients with relapsing-remitting multiple sclerosis. By now, phase II and III clinical trials are completed which demonstrated good tolerability, efficacy and relative safety of teriflunomide. The TEM...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
Remedium Group LLC
2015-12-01
|
| シリーズ: | Медицинский совет |
| 主題: | |
| オンライン･アクセス: | https://www.med-sovet.pro/jour/article/view/177 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|